Insider · CIK 0001551778

Malik Fady Ibraham

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001551778

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-20	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	16,386
2026-10-20	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$64.01	−$224K	153,902
2026-10-20	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-10-06	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-10-06	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$61.38	−$215K	153,902
2026-10-06	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	19,886
2026-09-22	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-09-22	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$68.29	−$239K	153,902
2026-09-22	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	23,386
2026-09-08	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-09-08	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$75.46	−$264K	153,902
2026-09-08	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	26,886
2026-08-18	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-08-18	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$75.82	−$265K	153,902
2026-08-18	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	30,386
2026-07-21	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-07-21	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$80.59	−$282K	153,902
2026-07-21	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	33,886
2026-07-07	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-07-07	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$86.62	−$303K	153,902
2026-07-07	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	37,386
2026-06-23	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-06-23	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$79.51	−$278K	153,902
2026-06-23	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	40,886
2026-06-18	RCKTROCKET PHARMACEUTICALS, INC.A Award	Director	AAward	+22.9K sh	—	—	52,862
2026-06-18	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+64.9K sh	—	—	64,860
2026-06-09	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-06-09	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$67.98	−$238K	153,902
2026-06-09	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	44,386
2026-05-19	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-05-19	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$75.69	−$265K	153,902
2026-05-19	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	47,886
2026-05-05	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-05-05	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$77.37	−$271K	153,902
2026-05-05	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	51,386
2026-04-21	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-04-21	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$65.69	−$230K	153,902
2026-04-21	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	54,886
2026-04-07	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+3,500 sh	$7.80	+$27.3K	157,402
2026-04-07	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−3,500 sh	$65.21	−$228K	153,902
2026-04-07	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP Research & Development	MExercise/Conversion	+1,000 sh	$10.60	+$10.6K	154,902
2026-04-07	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−1,000 sh	$64.75	−$64.8K	153,902
2026-04-07	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−3,500 sh	—	—	58,386
2026-04-07	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Research & Development	MExercise/Conversion	−1,000 sh	—	—	0
2026-03-17	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−7,636 sh	$62.15	−$475K	158,299
2026-03-17	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−4,397 sh	$62.15	−$273K	153,902
2026-03-15	CYTKCYTOKINETICS INCA Award	EVP Research & Development	AAward	+27.3K sh	—	—	165,935
2026-03-15	CYTKCYTOKINETICS INC · Incentive Stock Option (Right to Buy)A Award	EVP Research & Development	AAward	+1,665 sh	—	—	1,665
2026-03-15	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)A Award	EVP Research & Development	AAward	+39.5K sh	—	—	39,527
2026-03-09	CYTKCYTOKINETICS INCS Sale	EVP Research & Development	SSale	−2,907 sh	$60.72	−$177K	138,629

Recent filings

Accepted (ET)
Oct 204
Malik Fady Ibraham0001061983-26-000100
SEC(opens sec.gov)
Oct 64
Malik Fady Ibraham0001061983-26-000098
SEC(opens sec.gov)
Sep 224
Malik Fady Ibraham0001061983-26-000096
SEC(opens sec.gov)
Sep 84
Malik Fady Ibraham0001061983-26-000092
SEC(opens sec.gov)
Aug 184
Malik Fady Ibraham0001061983-26-000088
SEC(opens sec.gov)
Jul 234
Malik Fady Ibraham0001061983-26-000084
SEC(opens sec.gov)
Jul 74
Malik Fady Ibraham0001061983-26-000075
SEC(opens sec.gov)

Companies

Address

350 OYSTER POINT BLVD

SOUTH SAN FRANCISCO, CA, 94080